ATAI Life Sciences
Quarterly Financials
| Values in thousands | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
Revenue | $1,066 | $749 | $719 | $1,555 |
Gross Profit | 1,066 | 749 | 719 | -9,283 |
EBITDA | -6,099 | -60,734 | -27,162 | -19,054 |
EBIT | -6,435 | -60,967 | -27,389 | -19,270 |
Net Income | -544,813 | -61,074 | -27,729 | -26,431 |
Net Change In Cash | 1,066 | 749 | 719 | 1,555 |
Free Cash Flow | -48,253 | -28,624 | -19,221 | -18,109 |
Cash | 85,300 | 30,402 | 61,940 | 48,287 |
Basic Shares | 314,276 | 217,601 | 196,563 | 176,271 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $4,089 | $308 | $314 | $233 |
Gross Profit | 3,077 | 308 | 314 | 233 |
EBITDA | -113,049 | -144,808 | -36,311 | -134,091 |
EBIT | -114,061 | -145,281 | -36,630 | -134,259 |
Net Income | -660,047 | -149,269 | -40,224 | -152,385 |
Net Change In Cash | 4,089 | 308 | 314 | 233 |
Cost of Revenue | -170,530 | |||
Free Cash Flow | -103,576 | -82,532 | -84,708 | -105,491 |
Cash | 85,300 | 17,505 | 45,034 | 190,613 |
Basic Shares | 226,532 | 160,159 | 158,833 | 155,719 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-03-31 | $0 |
2025-12-31 | -$1.73 |
2025-09-30 | -$0.28 |
2025-06-30 | -$0.14 |
